Emerging leader nomination and contest

The 2011 International BIO Convention is around the corner for the team at Fierce. Not only does it start in less than three weeks, but it's also being held a few short blocks from Fierce HQ at the Washington Convention Center. We're also proud that John Carroll, FierceBiotech editor-in-chief, is a co-chair of this year's program committee.

To celebrate our close collaboration with BIO, we're holding an Emerging Leaders nomination contest. The lucky winner gets complimentary access to the following:

  • BIO's one-and-a-half day Emerging Leaders Workshop (more info here)
  • FierceBiotech's Best App in Town executive breakfast (more info here)
  • Access to the BIO Exhibition

Think of the emerging leaders in your organization. Then click here and take three minutes to nominate them. (Mid-level product and marketing managers with two to five years of experience are an ideal target.)

Competition is aggressive and evolving regulatory pressures require future drug development leaders to posses a dynamic mix of logistical and strategic knowledge. New product commercialization is a critical skill, which is why we're extending this contest to the future leaders of this industry reading FierceBiotech today.

Winners will be announced late next week. Hurry, nomination deadline is this Friday, June 10. - Arsalan Arif (twitter | email)

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.